fda semaglutide obesity New Weight Loss Medication Wegovy™ Approved by the FDA approves obesity drug that

Across the trials, when people stop the medication, the weight tends to come back, on the order of two-thirds of what was lost within a year

As response rate in this task is primarily used to detect nonspecific behavioral suppression, such as sedation or malaise, modest increases are difficult to interpret and are better evaluated using intake-based assessments

The lyophilization process enhances the shelf life of the product by minimizing moisture content, helping to maintain potency and quality until reconstitution and administration

It is important to consult with a healthcare provider for a complete understanding of potential risks and how to manage them